Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Laura Lenza"'
Autor:
Caterina Carbonell, Joan Frigola, Nuria Pardo, Ana Callejo, Patricia Iranzo, Augusto Valdivia, Ilaria Priano, Susana Cedrés, Alex Martinez‐Marti, Alejandro Navarro, Laura Lenza, Mireia Soleda, Javier Gonzalo‐Ruiz, Ana Vivancos, Miriam Sansó, Enric Carcereny, Teresa Morán, Ramon Amat, Enriqueta Felip
Publikováno v:
Molecular Oncology, Vol 17, Iss 5, Pp 779-791 (2023)
Immune checkpoint inhibitors (ICIs) targeting the PD‐1/PD‐L1 axis are the main therapeutic option for patients with advanced non‐small cell lung cancer (NSCLC) without a druggable oncogenic alteration. Nevertheless, only a portion of patients b
Externí odkaz:
https://doaj.org/article/604e6cdc2d234a06b5347b1a01ff2632
Autor:
Caterina Carbonell, Joan Frigola, Nuria Pardo, Ana Callejo, Patricia Iranzo, Augusto Valdivia, Ilaria Priano, Susana Cedrés, Alex Martinez‐Marti, Alejandro Navarro, Laura Lenza, Mireia Soleda, Javier Gonzalo‐Ruiz, Ana Vivancos, Miriam Sansó, Enric Carcereny, Teresa Morán, Ramon Amat, Enriqueta Felip
Publikováno v:
Scientia
Immune checkpoint inhibitors; Liquid biopsy Inhibidores del punto de control inmunitario; Biopsia líquida Inhibidors del punt de control immunitari; Biòpsia líquida Immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis are the main the
Autor:
null Caterina Carbonell, null Joan Frigola, null Nuria Pardo, null Ana Callejo, null Patricia Iranzo, null Augusto Valdivia, null Ilaria Priano, null Susana Cedrés, null Alex Martinez‐Marti, null Alejandro Navarro, null Laura Lenza, null Mireia Soleda, null Javier Gonzalo‐Ruiz, null Ana Vivancos, null Miriam Sansó, null Enric Carcereny, null Teresa Morán, null Ramon Amat, null Enriqueta Felip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53fb5ec0ecd09e6431a3b5b7a48b0577
https://doi.org/10.1002/1878-0261.13409/v2/response1
https://doi.org/10.1002/1878-0261.13409/v2/response1